Zimmer Biomet Names New SVP, Chief Strategy, Innovation & Business Development Officer

Zimmer Biomet Holdings has appointed Jehanzeb Noor as the Senior Vice President, Chief Strategy, Innovation, and Business Development Officer. He will also serve as the Chief of Staff to the CEO. He will report to the President and CEO of Zimmer Biomet, Ivan Tornos.

“I’m thrilled to welcome Jehanzeb to Zimmer Biomet,” said Tornos. “Over the course of his career, Jehanzeb has consistently demonstrated an impressive track record of significantly improving execution, culture and results. As we continue to boldly execute against our strategy and pursue innovation, I am confident Jehanzeb will be instrumental to our long-term success and deliver value for patients, surgeons, health systems and shareholders.”

Noor will lead strategy development and execution of M&A, including the pending acquisition of Paragon 28. In addition, he will have oversight of the research and product development organizations, inclusive of new product and service development, partnership and ecosystem development, and platform technologies. 

Before Zimmer Biomet, Noor served as President and Managing Director for Europe, Africa, and Asia at Trivium, where he led Trivium’s top & bottom-line transformation to drive operational excellence for margin and cash expansion. Prior to Trivium, Noor was CEO of Smiths Medical for three years and held roles of increasing responsibility at Amcor, McKinsey, Ford Motor Company, and Constellation Energy Commodities Group.